Studies in rodents have shown that changes in the gut microbiome, such as an increase in the genus Firmicutes, correlate with changes in the regulation of insulin levels, such as the presence or progression of obesity, type 2 diabetes, and the metabolic syndrome [44]. This evidence concerns the gene INS and metabolic syndrome.